RESEARCH PAPER
The impact of economic factors on the realities of outpatient multi-drug treatment of chronic diseases in rural areas.
 
More details
Hide details
1
Department of Health Education, University of Szczecin
2
Department of Pediatric Endocrinology and Neurology, Medical University of Lublin
CORRESPONDING AUTHOR
Katarzyna Sygit   

Department of Health Education, University of Szczecin; Katarzyna Sygit, 71-483 Szczecin, ul. Malinowa 11 A
 
Ann Agric Environ Med. 2011;18(1):29–34
KEYWORDS
ABSTRACT
The reform of the health care system in Poland introduced in 1999 brought not ony a lot of disappointments arising from the failure in performing its basic assumptions, but also from the deterioration in access to medical care by patients coming from the poorest class of the Polish population. The subjects were 209 people at the age of 52-80 years including 149 women and 60 men - inhabitants of rural areas of Lublin province. These were outpatients who attended the Endocrine Clinic in Poniatowa. The studies were conducted with the use of the standardized survey questionnaire. Of all 209 respondents requiring long-term multidrug therapies for chronic diseases, 128 (61.2 percent of those surveyed) reported episodic or permanent noncompliance to treatment regimens, 90 people (43 percent) had applied medications in a way at variance with medical recommendations. Among the reasons, economic factors were most often mentioned. Ony 21 respondents (10 percent) expressed the opinion that they had always possessed sufficient means to buy necessary drugs. Current regulations concerning the refunding of costs of medicines may make effective outpatient treatment of chronic diseases impossible. Almost 61.2 percent of the polled treated themselves contrary to medical recommendations. In most cases, improper courses of treatment were caused by financial problems.
 
REFERENCES (24)
1.
Bhutada NS, Cook CL, Perri M 3rd: Consumers responses to coupons in direct-to-consumer advertising of prescription drugs. Health Mark Q 2009, 26, 333–346.
 
2.
Blecharz-Klin K, Piechal A, Pyrzanowska J, Widy-Tyszkiewicz E: Herbal drug intera ctions in respira tory diseases. Herba Polonica 2005, 51, 89–107.
 
3.
Cunningham C, Dolan J, Equale J, Holdridge G, Lisowski D, Pierce K, Wiseman T, Zucker J: Elderly and disabled tax relief review committee report and recommendations, 2009. Available from: www.wiltonct.org.
 
4.
Das K, Ghosh M, Khanna B, Banerjee M, Mondal GP, Singh OP, Chakraborty A: Discontinuation of secondary preventive treatment of stroke: An unexplored scenario in India. Clin Neurol Neurosurg 2010, 112, 766–769.
 
5.
Delafuente JC: Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol 2003, 48, 133–143.
 
6.
Fugh-Berman A: Herb-drug interactions. Lancet 2000, 355, 134– 138.
 
7.
GUS: Gospodarstwa Domowe Dochody i Wydatki w 2009 roku. GUS, Lublin 2010.
 
8.
Hershman DL, Kushi LH, Shao T, Buono D, Kershenbaum A, Tsai WY, Fehrenbacher L, Lin Gomez S, Miles S, Neugut AI: Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. J Clin Oncol 2010, 28, 4120–4128.
 
9.
Huk-Wielczuk E: Physical work load and state of health of schoolaged children in the Southern Podlasie Region. Ann Agric Environ Med 2005, 12, 95–100.
 
10.
Kurier Lubelski: Co trzeci pacjent nie wykupuje leków. Kurier Lubelski 2010, 02-02.
 
11.
Ling CD, Berndt ER, Kyle MK: Deregulating direct-to-consumer marketing of prescription drugs: effects on prescription and over-thecounter product sales. J Law Econ 2002, 45, 691–723.
 
12.
Łoń I, Kuch-Wocial A, Maciejewska M: How to treat complicated hypertension today? Kardiol Prakt 2007, 4, 172–178.
 
13.
Montgomery MR: Urban poverty and health in developing countries. Popul Bull 2009, 64, 1–20.
 
14.
Naczelna Izba Aptekarska: Co trzecia osoba nie wykupuje wszystkich przepisanych na recepcie leków. PTWP OnLine Sp. z o.o., 2 February 2010. Available from: www.rynekaptek.pl. 15. Nerlewski PT: Opinie o reformie służby zdrowia. Przew Lek 2001, 4, 6–10.
 
15.
Nojszewska E, Miller J: Raport Otwarcia – System Ochrony Zdrowia w Polsce. Tendencje i perspektywy rozwoju polskiej gospodarki. Konferencja: Tendencje i perspektywy rozwoju polskiej gospodarki, 1–12. Warsaw 2007.
 
16.
Obywatelski Ośrodek Konsultacji Społecznych: Reforma systemu ochrony zdrowia w opiniach: samorządów, organizacji pozarządowych, związków zawodowych. Obywatelski Ośrodek Konsultacji Społecznych. Warszawa 2008. Available from: www.konsultacje-spoleczne.net.
 
17.
Rodrigues IL, Monteiro LL, Pacheco RH, da Silva SE: Abandonment of tuberculosis treatment among patients co-infected with TB/HIV. Rev Esc Enferm USP 2010, 44, 383–387.
 
18.
Schabowski J, Pitera J: Peptic ulcer among rural population in a selected region of South-Eastern Poland. Ann Agric Environ Med 2004, 11, 323–327.
 
19.
Sroka J, Wójcik-Fatla A, Dutkiewicz J: Occurrence of toxoplasma gondii in water from wells located on farms. Ann Agric Environ Med 2006, 13, 169–175.
 
20.
Ulgi podatkowe dla niepełnosprawnych. DzU 2000, No 14, item 176.
 
21.
Widjanarko B, Gompelman M, Dijkers M, van der Werf MJ: Factors that infl uence treatment adherence of tuberculosis patients living in Java, Indonesia. Patient Prefer Adherence 2009, 3, 231–238.
 
22.
Wójcik E, Ruciński P, Wójcik M, Wdowiak L: Wpływ reformy systemu opieki zdrowotnej w Polsce na dostępność świadczeń stomatologicznych w opinii pacjentów. Ann Univ Mariae Curie Sklodowska Med 2003, 58, 503–507.
 
23.
Zgierska A: Measurement of material poverty range in Poland in 2008 with the use of various poverty lines. In: Zgierska A (Ed): Household budget surveys in 2008, 54–56. Zakład Wydawnictw Statystycznych, Warsaw 2009.
 
24.
Zgierska A: The situation of households in 2008 based on the household budget surveys. In: Zgierska A (Ed): Household budget surveys in 2008, 37–53. Zakład Wydawnictw Statystycznych, Warsaw 2009.
 
eISSN:1898-2263
ISSN:1232-1966